NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

And that is not true and that is not how this works. You fundamentally misunderstand the complexity and possibilities of what they will receive. You are equating data from the statistical firm with rejection by the FDA, and they are not the same thing.

You also took one sentence out of the fuller context. I choose to give fuller answers. It’s late, they may be stream of consciousness but they also thoroughly address a range of details. You’re also oversimplifying. The 4 day rule does not require that immediate disclosure. It is optional. They have said they will disclose, so I believe they will. But the notion that failure to disclose necessarily means that they hit their endpoints because “the law”... is a flawed conclusion based upon a flawed and often illogically convoluted set of assumptions and contingencies by people who might not want to induce reliance by others based upon nonsense and false assumptions.

“No not asserting any such thing as "if they fail to disclose that means trial did not fail." I am simply stating if management gets a report from the statisticians the company hired to run the data against the end points and the Primary Endpoint fails then the Company had a duty to disclose that to shareholders. Very basic. There are no assurances that the trial did not fail. The company may not have the report from the statisticians. The Company could also breach the duty to disclose. Most likely is the report is not ready yet or has not been communicated to management. “